{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:37:45Z","timestamp":1789238265174,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2000,10,24]]},"DOI":"10.1212\/wnl.55.8.1106","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:49:12Z","timestamp":1336916952000},"page":"1106-1109","source":"Crossref","is-referenced-by-count":166,"title":["Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?"],"prefix":"10.1212","volume":"55","author":[{"given":"P.","family":"Genton","sequence":"first","affiliation":[{"name":"From the Centre Saint Paul (Drs. Genton, Gelisse, and Dravet), Marseille; and the Clinique Neurologique (Dr. Thomas), Ho\u0302pital Pasteur, Nice, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gelisse","sequence":"additional","affiliation":[{"name":"From the Centre Saint Paul (Drs. Genton, Gelisse, and Dravet), Marseille; and the Clinique Neurologique (Dr. Thomas), Ho\u0302pital Pasteur, Nice, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Thomas","sequence":"additional","affiliation":[{"name":"From the Centre Saint Paul (Drs. Genton, Gelisse, and Dravet), Marseille; and the Clinique Neurologique (Dr. Thomas), Ho\u0302pital Pasteur, Nice, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dravet","sequence":"additional","affiliation":[{"name":"From the Centre Saint Paul (Drs. Genton, Gelisse, and Dravet), Marseille; and the Clinique Neurologique (Dr. Thomas), Ho\u0302pital Pasteur, Nice, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","first-page":"346","volume":"176","year":"1957","unstructured":"Janz D, Christian W. Impulsiv Petit-Mal. Dtsch Z Nervenheilk . 1957; 176: 346\u2013386.","journal-title":"Dtsch Z Nervenheilk"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.3.285"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1984.tb04163.x"},{"key":"e_1_3_2_5_2","unstructured":"Wolf   P.   Juvenile myoclonic epilepsy.  In:  Roger  J Bureau  M Dravet  Ch Dreifuss  FE Perret  A Wolf  P eds.  Epileptic syndromes in infancy childhood and adolescence 2nd ed.   London:   John Libbey 1992:  313\u2013327."},{"key":"e_1_3_2_6_2","unstructured":"Genton   P Salas Puig   J Tunon   A Lahoz   C Gonzalez Sanchez   M.   Juvenile myoclonic epilepsy and related syndromes: clinical and neurophysiological aspects.  In:  Malafosse  A Genton  P Hirsch  E Marescaux  C Broglin  D Bernasconi  R eds.  Idiopathic generalized epilepsies: clinical experimental and genetic aspects.   London:   John Libbey 1994:  253\u2013265."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01268.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1996.tb00047.x"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1528-1157.1998.tb02601.x","volume":"39","year":"1998","unstructured":"Guerrini R, Belmonte A, Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia . 1998; 39 (suppl 3): S2\u2013S10.","journal-title":"Epilepsia"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb05143.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"e_1_3_2_12_2","unstructured":"Janz   D.   Die Epilepsien.   Stuttgart:   Thieme Verlag 1969."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.6.497"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb02434.x"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb06000.x"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(05)80097-4"},{"key":"e_1_3_2_17_2","first-page":"285","volume":"25","year":"1995","unstructured":"Genton P, Gonzales Sanchez MDS, Saltarelli A, Bureau M, Dravet C, Roger J. Aspects trompeurs de l\u2019EEG standard dans l\u2019\u00e9pilepsie myoclonique juv\u00e9nile: \u00e9tude r\u00e9trospective de 56 cas cons\u00e9cutifs. Neurophysiol Clin . 1995; 25: 285\u2013290.","journal-title":"Neurophysiol Clin"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(98)90010-3"},{"key":"e_1_3_2_19_2","first-page":"S19","volume":"30","year":"1989","unstructured":"Penry JK, Dean JC, Riela AR. Juvenile myoclonic epilepsy: long-term response to therapy. Epilepsia . 1989; 30 (suppl 4): S19\u201323.","journal-title":"Epilepsia"},{"key":"e_1_3_2_20_2","unstructured":"Jeavons   PM Covanis   A Gupta   AK Clark   JE.   Monotherapy with sodium valproate in childhood epilepsy.  In:  Parsonage  MJ Caldwell  ADS eds.  The place of sodium valproate in the treatment of epilepsy.   London:   Academic Press 1980:  53\u201358."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1988.tb03718.x"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1996.tb01844.x"},{"key":"e_1_3_2_23_2","unstructured":"Wilder   BJ.   Phenytoin. Clinical use.  In:  Levy  RH Mattson  RH Meldrum  BS eds.  Antiepileptic drugs 4th ed.   New York:   Raven Press 1995:  339\u2013344."},{"key":"e_1_3_2_24_2","first-page":"503.","volume":"57","year":"1994","unstructured":"Knott C, Panayiotopoulos CP. Carbamazepine in the treatment of generalised tonic clonic seizures in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry . 1994; 57: 503.Letter.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_2_25_2","first-page":"S5","volume":"35","year":"1994","unstructured":"McLean MJ, Schmutz M, Wamil AW, Olpe HR, Portet C, Feldmann KF. Oxcarbazepine: mechanisms of action. Epilepsia . 1994; 35 (suppl 3): S5\u2013S9.","journal-title":"Epilepsia"},{"key":"e_1_3_2_26_2","first-page":"295","volume":"72","year":"1985","unstructured":"Pedersen SA, Klosterskov P, Gram L, Dam M. Long-term study of gamma-vinyl GABA in the treatment of epilepsy. Acta Neurol Scand . 1985; 72: 295\u2013298.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_2_27_2","first-page":"1467.","volume":"49","year":"1997","unstructured":"Panayiotopoulos CP, Agathonikou A, Sharoqi IA, Parker AP. Vigabatrin aggravates absences and absence status. Neurology . 1997; 49: 1467.","journal-title":"Neurology"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1998.tb15409.x"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(96)80110-5"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.66.6.759"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.11.1677"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(96)80062-8"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.55.8.1106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:31:38Z","timestamp":1711643498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.55.8.1106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,24]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000,10,24]]}},"alternative-id":["10.1212\/WNL.55.8.1106"],"URL":"https:\/\/doi.org\/10.1212\/wnl.55.8.1106","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10,24]]}}}